Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Answer of 7 October 2019 to Question 292911 on Dietary Supplements: Expenditure, in what situations and to treat which illnesses are the probiotics listed in that Answer prescribed.

Prior to being delisted from Part XV of the Drug Tariff, VSL#3 and Vivomixx were approved by the Advisory Committee on Borderline Substances (ACBS) and recommended for prescribing ‘For use under the supervision of a physician for the maintenance of antibiotic induced remission of ileoanal pouchitis in adults.’

Symprove was never recommended for prescribing by the ACBS.